Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic-hypothalamic low-grade glioma.
Fatema MalbariMurali M ChintagumpalaAlexis C WoodAdam S LevyJack M SuM Fatih OkcuFrank Y LinHolly LindsaySurya P RednamPatricia A BaxterArnold C PaulinoGuillermo Aldave OrzaizWilliam E WhiteheadRobert DauserNucharin SupakulStephen F KralikPublished in: Pediatric blood & cancer (2021)
MRI without GBCA effectively identifies patients with progressive disease. When imaging children with CHLGG, eliminating GBCA should be considered unless monitoring patients with metastatic disease.